SP Accure Labs Private Limited — Cisplatin Exporter Profile
Indian Pharmaceutical Exporter · #10 for Cisplatin · $233.8K export value · DGFT Verified
SP Accure Labs Private Limited is the #10 Indian exporter of Cisplatin with $233.8K in export value and 27 verified shipments. SP Accure Labs Private Limited holds a 1.8% market share in Cisplatin exports across 9 countries. The company exports 14 pharmaceutical products worth $3.5M across 3 therapeutic categories.
SP Accure Labs Private Limited — Cisplatin Export Profile: Buyers & Destinations
Where Does SP Accure Labs Private Limited Export Cisplatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $106.8K | 5 | 45.5% |
| TURKMENISTAN | $42.2K | 4 | 18.0% |
| MEXICO | $41.0K | 2 | 17.5% |
| GAUTEMALA | $12.1K | 2 | 5.1% |
| GUATEMALA | $8.8K | 1 | 3.8% |
| NEPAL | $8.8K | 4 | 3.8% |
| NAMIBIA | $6.6K | 2 | 2.8% |
| GUYANA | $2.9K | 1 | 1.2% |
| UNITED KINGDOM | $2.8K | 5 | 1.2% |
| NAMBIA | $2.0K | 1 | 0.8% |
SP Accure Labs Private Limited exports Cisplatin to 11 countries. The largest destination is NETHERLANDS accounting for 45.5% of SP Accure Labs Private Limited's Cisplatin shipments, followed by TURKMENISTAN (18.0%) and MEXICO (17.5%). These destinations reflect SP Accure Labs Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cisplatin from SP Accure Labs Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| IMRES B.V | NETHERLANDS | $106.8K | 5 |
| UNDP OFFICE | TURKMENISTAN | $42.2K | 4 |
| COMPETITIVDAD Y DESARROLO | MEXICO | $41.0K | 2 |
| GETICS S.A | GUATEMALA | $8.8K | 1 |
| BIOKAL SOCIEDAD ANONIMA BIKASA | GAUTEMALA | $8.1K | 1 |
| WINDHOEK MEDICAL SOLUTIONS(PTY)LTD | NAMIBIA | $6.6K | 2 |
| TAJ NEPAL PVT L.T.D | NEPAL | $4.2K | 1 |
| DROGUERIA BIKASA | GAUTEMALA | $3.9K | 1 |
| NEW GPC INC | GUYANA | $2.9K | 1 |
| ARC PHARMA UK LIMITED | UNITED KINGDOM | $2.8K | 5 |
SP Accure Labs Private Limited supplies Cisplatin to 15 buyers globally. The largest buyer is IMRES B.V (NETHERLANDS), followed by UNDP OFFICE (TURKMENISTAN) and COMPETITIVDAD Y DESARROLO (MEXICO). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cisplatin Export Value and How Much Does SP Accure Labs Private Limited Contribute?
India exported $9.6M worth of Cisplatin through 1,701 shipments from 233 suppliers to 130 countries, serving 584 buyers globally. SP Accure Labs Private Limited contributes $233.8K to this total, accounting for 1.8% of India's Cisplatin exports. SP Accure Labs Private Limited ships Cisplatin to 11 countries through 15 buyers.
What Is the Average Shipment Value for SP Accure Labs Private Limited's Cisplatin Exports?
SP Accure Labs Private Limited's average Cisplatin shipment value is $8.7K per consignment, based on 27 shipments totaling $233.8K. The largest destination is NETHERLANDS (45.5% of SP Accure Labs Private Limited's Cisplatin exports).
How Does SP Accure Labs Private Limited Compare to Other Indian Cisplatin Exporters?
SP Accure Labs Private Limited ranks #10 among 233 Indian Cisplatin exporters with a 1.8% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($2.8M), VENUS REMEDIES LIMITED ($1.7M), INTAS PHARMACEUTICALS LIMITED ($1.5M). SP Accure Labs Private Limited processed 27 shipments to 9 destination countries.
What Cisplatin Formulations Does SP Accure Labs Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CISPLATIN CONCENTRATE FOR SOLUTION FOR I | $106.8K | 5 |
| CISPLATIN CONCENTRATE FOR SOLUTION FOR INFUSION BP 10MG/10ML | $41.0K | 2 |
| CISPLATIN CONCENTRATE FOR SOLUTION FOR INFUSION BP 50MG/50ML BATCH NO. 23JCS04 MANUFACTURING .DT.10-23 EXP.DT. 09/25 | $10.8K | 1 |
| CISPLATIN CONCENTRATE FOR SOLUTION FOR INFUSION BP 50MG/50ML BATCH NO. 23JCS05 MANUFACTURING .DT.10-23 EXP.DT.09/25 | $10.7K | 1 |
| CISPLATIN CONCENTRATE FOR SOLUTION FOR INFUSION BP 50MG/50ML BATCH NO. 23JCS03 MANUFACTURING .DT.10-23 EXP.DT.09/25 | $10.4K | 1 |
| CISPLATIN CONCENTRATE FOR SOLUTION FOR INFUSION BP 50MG/50ML BATCH NO. 23JCS02 MANUFACTURING .DT.10-23 EXP.DT.09/25 | $10.3K | 1 |
| CISPLATIN CONCENTRATE FOR SOLUTION FOR INFUSION BP 50 MG/50ML | $8.8K | 1 |
| CIS SPAL L50 CISPLATIN SOLUTION FOR INJECTION 50 MG | $8.1K | 1 |
| CISPLATIN CONCENTRATE FOR SOLUTION FOR INFUSION BP 50MG/50 ML (ANTICANCER DRUGS-OTHERS) | $6.6K | 2 |
| CIS SPALI L-50 (CISPLATIN CONCENTRATE FO | $4.2K | 1 |
SP Accure Labs Private Limited exports 22 distinct Cisplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CISPLATIN CONCENTRATE FOR SOLUTION FOR I with 5 shipments worth $106.8K.
Regulatory Requirements: Exporting Cisplatin to Key Markets
What SP Accure Labs Private Limited must comply with to export Cisplatin to its top destination countries
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SP Accure Labs Private Limited Compare to Nearest Cisplatin Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | UNITED BIOTECH PRIVATE LIMITED | $489.4K | 97 | 14 | $5.0K |
| 9 | INTAS PHARMACEUTICALS LTD | $268.6K | 15 | 9 | $17.9K |
| 10 | SP ACCURE LABS PRIVATE LIMITED ★ | $233.8K | 27 | 9 | $8.7K |
| 11 | MEDORBIS TRADE LLP | $208.8K | 11 | 2 | $19.0K |
| 4 | NV REMEDIES PRIVATE LIMITED | $200.0K | 4 | 1 | $50.0K |
SP Accure Labs Private Limited ranks #10 among 233 Indian Cisplatin exporters. Average shipment value of $8.7K compared to the market average of $41.2K. The closest competitors by value are UNITED BIOTECH PRIVATE LIMITED and INTAS PHARMACEUTICALS LTD.
Which Indian Ports Ship Cisplatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 300 | 17.6% |
| SAHAR AIR | 281 | 16.5% |
| DELHI AIR CARGO ACC (INDEL4) | 260 | 15.3% |
| DELHI AIR | 237 | 13.9% |
| Bombay Air | 104 | 6.1% |
| Delhi Air | 53 | 3.1% |
| Delhi Air Cargo | 37 | 2.2% |
| HYDERABAD ACC (INHYD4) | 35 | 2.1% |
What Other Oncology Products Does SP Accure Labs Private Limited Export?
SP Accure Labs Private Limited also exports these oncology products. Each links to the detailed product page.
About SP Accure Labs Private Limited
SP Accure Labs Private Limited exports 14 products worth $3.5M. Beyond Cisplatin, top products include Paclitaxel, Protein, Bortezomib, Pazopanib, Cyclophosphamide. View the complete SP Accure Labs Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cisplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cisplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SP Accure Labs Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 28 individual customs records matching SP Accure Labs Private Limited exporting Cisplatin, covering 22 formulations to 11 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 130+ countries, 584+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cisplatin Export Data from SP Accure Labs Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SP Accure Labs Private Limited's Cisplatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SP Accure Labs Private Limited
Full Company Profile →
14 products · $3.5M total trade · 3 categories
Cisplatin Stats
Company Overview
Top Products by SP Accure Labs Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SP Accure Labs Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cisplatin. For current shipment-level data, contact TransData Nexus.